NAV3/27/2017 Chg.+2.5900 Type of yield Investment Focus Investment company
553.0600EUR +0.47% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - - -2.45 6.30 6.58 -0.94 3.24 -11.67 4.98 5.10 -
2010 4.70 4.84 5.87 0.14 -4.99 -3.21 -3.09 0.49 4.34 4.57 1.80 4.34 +20.78%
2011 -4.93 -0.52 -1.71 3.48 3.28 -1.57 -1.16 -13.41 -0.17 1.99 4.08 6.82 -5.27%
2012 12.52 -0.44 3.83 1.03 6.49 1.14 7.03 -0.33 3.59 -9.18 4.64 -1.86 +30.44%
2013 4.47 5.61 9.77 6.55 4.77 -4.15 12.35 -2.03 6.33 -3.56 8.10 -0.15 +57.85%
2014 12.43 4.14 -10.65 -4.57 4.54 8.21 1.21 13.15 3.08 11.08 3.16 2.38 +56.40%
2015 15.76 6.41 5.03 -7.83 12.31 -1.95 2.94 -12.77 -11.98 10.68 7.11 -1.84 +20.78%
2016 -22.77 -5.53 -0.31 3.53 6.38 -9.16 12.51 -2.37 2.05 -11.83 12.41 -3.35 -21.86%
2017 4.94 9.09 -2.71 - - - - - - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 21.07% 28.49% 27.39% 30.66% 27.16%
Sharpe ratio 2.89 0.25 0.75 0.53 0.90
Best month +9.09% +12.41% +12.51% +15.76% +15.76%
Worst month -3.35% -11.83% -11.83% -22.77% -22.77%
Maximum loss -7.18% -19.15% -19.80% -44.14% -44.14%
Outperformance +4.81% - +5.45% +10.55% +69.47%
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 449.4600 +16.90% +23.84%
BB Adamant Biotech I EUR reinvestment 553.0600 +20.14% +56.33%
BB Adamant Biotech I CHF reinvestment 389.5800 +17.82% +37.34%
BB Adamant Biotech I GBP reinvestment 377.8500 - -
BB Adamant Biotech B USD reinvestment 423.5800 +16.05% +21.12%
BB Adamant Biotech B CHF reinvestment 365.1700 +16.96% +34.31%
BB Adamant Biotech B EUR reinvestment 519.2800 +19.26% +52.89%

Performance

YTD  
+11.38%
6 Months  
+3.29%
1 Year  
+20.14%
3 Years  
+56.33%
5 Years  
+192.95%
Since start  
+342.45%
Year
2016
  -21.86%
2015  
+20.78%
2014  
+56.40%
2013  
+57.85%
2012  
+30.44%
2011
  -5.27%
2010  
+20.78%